Bioengineering / Biyomühendislik
Permanent URI for this collectionhttps://hdl.handle.net/11147/4529
Browse
3 results
Search Results
Now showing 1 - 3 of 3
Article Novel Coronavirus Disease: Overview and Recent Situation(İstanbul Üniversitesi-Cerrahpaşa Sağlık Bilimleri Fakültesi, 2020) Öksel, Ceyda; Bilgi, Eyüp; Başlar, Muhammet Semih; Çeşmeli, Selin; Tomak, Aysel; Hanoğlu, Berçem DilanIn the last days of 2019, local hospitals in Wuhan city (population of 11 million) reported several pneumonia cases with unknown etiology among people linked to the Huanan Seafood Wholesale Market. The virus, which is thought to be the source of the unknown viral infection, was first identified as a new type of coronavirus on January 7, 2020. With the first case reported in Thailand about a week later, the virus’s spread outside the borders of China became apparent. In an alarmingly short time, the new type of coronavirus disease (called COVID-19) started to gain worldwide recognition with the detection of various COVID-19 cases in multiple countries, including Japan, South Korea, USA, Singapore, France, Germany, Italy, Spain, and England. As a result of its rampant spread and fatal clinical manifestations, the coronavirus outbreak was declared a pandemic on March 11, 2020, by the World Health Organization (WHO). Turkey announced its first confirmed case of COVID-19 on the same date that WHO characterized COVID-19 as a pandemic. As of April 2020, the COVID-19 pandemic has traveled to 209 countries and territories around the world, infecting more than 3 million people. Since specific treatment and vaccine for COVID-19 are not yet available, early case detection and preventive healthcare practices (isolation, social distancing, and personal hygiene) play a critical role in combating the COVID-19 outbreak. This review is intended to build an overall picture of the COVID-19 outbreak based on the available scientific knowledge.Article Citation - WoS: 11Citation - Scopus: 11The Importance of Neopterin in Covid-19: The Prognostic Value and Relation With the Disease Severity(Elsevier, 2022) Rasmi, Yousef; Heidari, Nadia; Kübra Kırboğa, Kevser; Hatamkhani, Shima; Tekin, Burcu; Alipour, Shahryar; Naderi, Roya; Farnamian, Yeghaneh; Akça, İlknurCoronavirus Disease 2019 [COVID-19], caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], has rapidly evolved into a global health emergency. Neopterin [NPT], produced by macrophages when stimulated with interferon [IFN-]gamma, is an essential cytokine in the antiviral immune response. NPT has been used as a marker for the early assessment of disease severity in different diseases. The leading cause of NPT production is the pro-inflammatory cytokine IFN-. Macrophage activation has also been revealed to be linked with disease severity in SARS-CoV-2 patients. We demonstrate the importance of NPT in the pathogenesis of SARS-CoV-2 and suggest that targeting NPT in SARS-CoV-2 infection may be critical in the early prediction of disease progression and provision of timely management of infected individuals.Article Citation - WoS: 37Citation - Scopus: 48Microfluidic-Based Virus Detection Methods for Respiratory Diseases(Springernature, 2021) Tarım, Ergün Alperay; Karakuzu, Betül; Öksüz, Cemre; Sarıgil, Öykü; Kızılkaya, Melike; Al-Ruweidi, Mahmoud Khatib A. A.; Yalçın, Hüseyin Çağatay; Özçivici, Engin; Tekin, Hüseyin CumhurWith the recent SARS-CoV-2 outbreak, the importance of rapid and direct detection of respiratory disease viruses has been well recognized. The detection of these viruses with novel technologies is vital in timely prevention and treatment strategies for epidemics and pandemics. Respiratory viruses can be detected from saliva, swab samples, nasal fluid, and blood, and collected samples can be analyzed by various techniques. Conventional methods for virus detection are based on techniques relying on cell culture, antigen-antibody interactions, and nucleic acids. However, these methods require trained personnel as well as expensive equipment. Microfluidic technologies, on the other hand, are one of the most accurate and specific methods to directly detect respiratory tract viruses. During viral infections, the production of detectable amounts of relevant antibodies takes a few days to weeks, hampering the aim of prevention. Alternatively, nucleic acid-based methods can directly detect the virus-specific RNA or DNA region, even before the immune response. There are numerous methods to detect respiratory viruses, but direct detection techniques have higher specificity and sensitivity than other techniques. This review aims to summarize the methods and technologies developed for microfluidic-based direct detection of viruses that cause respiratory infection using different detection techniques. Microfluidics enables the use of minimal sample volumes and thereby leading to a time, cost, and labor effective operation. Microfluidic-based detection technologies provide affordable, portable, rapid, and sensitive analysis of intact virus or virus genetic material, which is very important in pandemic and epidemic events to control outbreaks with an effective diagnosis.
